nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—ABCB1—Liothyronine—hypothyroidism	0.0873	0.28	CbGbCtD
Haloperidol—ABCB1—Levothyroxine—hypothyroidism	0.0873	0.28	CbGbCtD
Haloperidol—ABCB1—Liotrix—hypothyroidism	0.0852	0.273	CbGbCtD
Haloperidol—CYP3A4—Levothyroxine—hypothyroidism	0.0523	0.168	CbGbCtD
Haloperidol—Muscle twitching—Liothyronine—hypothyroidism	0.0155	0.0482	CcSEcCtD
Haloperidol—GRIN2B—nerve—hypothyroidism	0.0138	0.0549	CbGeAlD
Haloperidol—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.0135	0.042	CcSEcCtD
Haloperidol—Menstruation irregular—Levothyroxine—hypothyroidism	0.0135	0.042	CcSEcCtD
Haloperidol—Throat tightness—Liotrix—hypothyroidism	0.0112	0.0349	CcSEcCtD
Haloperidol—Menstruation irregular—Liotrix—hypothyroidism	0.0099	0.0309	CcSEcCtD
Haloperidol—HTR2A—cerebellar cortex—hypothyroidism	0.00878	0.035	CbGeAlD
Haloperidol—DRD1—nerve—hypothyroidism	0.00827	0.0329	CbGeAlD
Haloperidol—CYP2C19—urine—hypothyroidism	0.00731	0.0291	CbGeAlD
Haloperidol—Loperamide—POMC—hypothyroidism	0.00701	1	CrCbGaD
Haloperidol—Hyperkinesia—Levothyroxine—hypothyroidism	0.0065	0.0203	CcSEcCtD
Haloperidol—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.0065	0.0203	CcSEcCtD
Haloperidol—DRD4—heart—hypothyroidism	0.0061	0.0243	CbGeAlD
Haloperidol—CYP1A2—urine—hypothyroidism	0.00597	0.0238	CbGeAlD
Haloperidol—Hypertension—Liothyronine—hypothyroidism	0.00573	0.0179	CcSEcCtD
Haloperidol—CYP2C9—urine—hypothyroidism	0.00567	0.0226	CbGeAlD
Haloperidol—Muscle twitching—Liotrix—hypothyroidism	0.00558	0.0174	CcSEcCtD
Haloperidol—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00554	0.0173	CcSEcCtD
Haloperidol—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00554	0.0173	CcSEcCtD
Haloperidol—Tachycardia—Liothyronine—hypothyroidism	0.00528	0.0165	CcSEcCtD
Haloperidol—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00514	0.0161	CcSEcCtD
Haloperidol—Cardiac arrest—Levothyroxine—hypothyroidism	0.00514	0.0161	CcSEcCtD
Haloperidol—Hypotension—Liothyronine—hypothyroidism	0.00506	0.0158	CcSEcCtD
Haloperidol—DRD2—nerve—hypothyroidism	0.00488	0.0194	CbGeAlD
Haloperidol—EBP—liver—hypothyroidism	0.00485	0.0193	CbGeAlD
Haloperidol—Hyperkinesia—Liotrix—hypothyroidism	0.00478	0.0149	CcSEcCtD
Haloperidol—Dysphagia—Dextrothyroxine—hypothyroidism	0.00468	0.0146	CcSEcCtD
Haloperidol—Dysphagia—Levothyroxine—hypothyroidism	0.00468	0.0146	CcSEcCtD
Haloperidol—HTR2A—urine—hypothyroidism	0.00467	0.0186	CbGeAlD
Haloperidol—Sweating increased—Dextrothyroxine—hypothyroidism	0.00455	0.0142	CcSEcCtD
Haloperidol—Sweating increased—Levothyroxine—hypothyroidism	0.00455	0.0142	CcSEcCtD
Haloperidol—CYP3A4—urine—hypothyroidism	0.00432	0.0172	CbGeAlD
Haloperidol—Body temperature increased—Liothyronine—hypothyroidism	0.00428	0.0134	CcSEcCtD
Haloperidol—CYP2D6—urine—hypothyroidism	0.00425	0.0169	CbGeAlD
Haloperidol—Weight decreased—Dextrothyroxine—hypothyroidism	0.00423	0.0132	CcSEcCtD
Haloperidol—Weight decreased—Levothyroxine—hypothyroidism	0.00423	0.0132	CcSEcCtD
Haloperidol—Hypoglycaemia—Liotrix—hypothyroidism	0.00408	0.0127	CcSEcCtD
Haloperidol—CBR1—adrenal cortex—hypothyroidism	0.00392	0.0156	CbGeAlD
Haloperidol—CBR1—heart—hypothyroidism	0.00379	0.0151	CbGeAlD
Haloperidol—Cardiac arrest—Liotrix—hypothyroidism	0.00378	0.0118	CcSEcCtD
Haloperidol—DRD4—testis—hypothyroidism	0.00376	0.015	CbGeAlD
Haloperidol—CBR1—cardiovascular system—hypothyroidism	0.00358	0.0143	CbGeAlD
Haloperidol—Dysphagia—Liotrix—hypothyroidism	0.00344	0.0107	CcSEcCtD
Haloperidol—Bronchospasm—Liotrix—hypothyroidism	0.00338	0.0106	CcSEcCtD
Haloperidol—Sweating increased—Liotrix—hypothyroidism	0.00335	0.0105	CcSEcCtD
Haloperidol—Alopecia—Levothyroxine—hypothyroidism	0.00331	0.0103	CcSEcCtD
Haloperidol—Alopecia—Dextrothyroxine—hypothyroidism	0.00331	0.0103	CcSEcCtD
Haloperidol—CBR1—gonad—hypothyroidism	0.00325	0.0129	CbGeAlD
Haloperidol—HTR2A—nerve—hypothyroidism	0.00322	0.0128	CbGeAlD
Haloperidol—H1F0—adrenal cortex—hypothyroidism	0.00321	0.0128	CbGeAlD
Haloperidol—CBR1—pituitary gland—hypothyroidism	0.00317	0.0126	CbGeAlD
Haloperidol—Weight decreased—Liotrix—hypothyroidism	0.00311	0.00971	CcSEcCtD
Haloperidol—H1F0—heart—hypothyroidism	0.00311	0.0124	CbGeAlD
Haloperidol—Tremor—Dextrothyroxine—hypothyroidism	0.00305	0.00953	CcSEcCtD
Haloperidol—Tremor—Levothyroxine—hypothyroidism	0.00305	0.00953	CcSEcCtD
Haloperidol—Agitation—Levothyroxine—hypothyroidism	0.00299	0.00934	CcSEcCtD
Haloperidol—Agitation—Dextrothyroxine—hypothyroidism	0.00299	0.00934	CcSEcCtD
Haloperidol—UGT1A9—liver—hypothyroidism	0.00294	0.0117	CbGeAlD
Haloperidol—H1F0—cardiovascular system—hypothyroidism	0.00293	0.0117	CbGeAlD
Haloperidol—GRIN2B—cerebellum—hypothyroidism	0.00292	0.0116	CbGeAlD
Haloperidol—CBR1—adrenal gland—hypothyroidism	0.00283	0.0113	CbGeAlD
Haloperidol—CBR1—blood—hypothyroidism	0.00283	0.0113	CbGeAlD
Haloperidol—Convulsion—Dextrothyroxine—hypothyroidism	0.00282	0.00881	CcSEcCtD
Haloperidol—Convulsion—Levothyroxine—hypothyroidism	0.00282	0.00881	CcSEcCtD
Haloperidol—Anxiety—Dextrothyroxine—hypothyroidism	0.00276	0.00863	CcSEcCtD
Haloperidol—Anxiety—Levothyroxine—hypothyroidism	0.00276	0.00863	CcSEcCtD
Haloperidol—CBR1—thyroid gland—hypothyroidism	0.00273	0.0109	CbGeAlD
Haloperidol—Confusional state—Dextrothyroxine—hypothyroidism	0.00268	0.00837	CcSEcCtD
Haloperidol—Confusional state—Levothyroxine—hypothyroidism	0.00268	0.00837	CcSEcCtD
Haloperidol—H1F0—gonad—hypothyroidism	0.00266	0.0106	CbGeAlD
Haloperidol—CBR1—female gonad—hypothyroidism	0.00264	0.0105	CbGeAlD
Haloperidol—H1F0—pituitary gland—hypothyroidism	0.0026	0.0103	CbGeAlD
Haloperidol—Tachycardia—Dextrothyroxine—hypothyroidism	0.00259	0.0081	CcSEcCtD
Haloperidol—Tachycardia—Levothyroxine—hypothyroidism	0.00259	0.0081	CcSEcCtD
Haloperidol—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00257	0.00802	CcSEcCtD
Haloperidol—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00257	0.00802	CcSEcCtD
Haloperidol—CYP3A7—liver—hypothyroidism	0.00245	0.00974	CbGeAlD
Haloperidol—Alopecia—Liotrix—hypothyroidism	0.00243	0.00759	CcSEcCtD
Haloperidol—Insomnia—Levothyroxine—hypothyroidism	0.0024	0.00751	CcSEcCtD
Haloperidol—Insomnia—Dextrothyroxine—hypothyroidism	0.0024	0.00751	CcSEcCtD
Haloperidol—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00237	0.0074	CcSEcCtD
Haloperidol—Dyspnoea—Levothyroxine—hypothyroidism	0.00237	0.0074	CcSEcCtD
Haloperidol—HTR1B—cardiovascular system—hypothyroidism	0.00235	0.00934	CbGeAlD
Haloperidol—CBR1—testis—hypothyroidism	0.00234	0.00932	CbGeAlD
Haloperidol—SIGMAR1—adrenal cortex—hypothyroidism	0.00232	0.00924	CbGeAlD
Haloperidol—H1F0—adrenal gland—hypothyroidism	0.00232	0.00924	CbGeAlD
Haloperidol—H1F0—blood—hypothyroidism	0.00232	0.00924	CbGeAlD
Haloperidol—HTR2B—adrenal cortex—hypothyroidism	0.00232	0.00922	CbGeAlD
Haloperidol—HTR1D—cardiovascular system—hypothyroidism	0.00227	0.00905	CbGeAlD
Haloperidol—Vision blurred—Liotrix—hypothyroidism	0.00226	0.00705	CcSEcCtD
Haloperidol—Tremor—Liotrix—hypothyroidism	0.00224	0.00701	CcSEcCtD
Haloperidol—SIGMAR1—heart—hypothyroidism	0.00224	0.00894	CbGeAlD
Haloperidol—HTR2B—heart—hypothyroidism	0.00224	0.00892	CbGeAlD
Haloperidol—H1F0—thyroid gland—hypothyroidism	0.00224	0.00891	CbGeAlD
Haloperidol—CBR1—liver—hypothyroidism	0.00221	0.00881	CbGeAlD
Haloperidol—Agitation—Liotrix—hypothyroidism	0.0022	0.00687	CcSEcCtD
Haloperidol—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00219	0.00684	CcSEcCtD
Haloperidol—Feeling abnormal—Levothyroxine—hypothyroidism	0.00219	0.00684	CcSEcCtD
Haloperidol—H1F0—female gonad—hypothyroidism	0.00216	0.00861	CbGeAlD
Haloperidol—CBR1—cerebellum—hypothyroidism	0.00216	0.00861	CbGeAlD
Haloperidol—HTR2B—cardiovascular system—hypothyroidism	0.00211	0.00842	CbGeAlD
Haloperidol—Urticaria—Levothyroxine—hypothyroidism	0.00211	0.00659	CcSEcCtD
Haloperidol—Urticaria—Dextrothyroxine—hypothyroidism	0.00211	0.00659	CcSEcCtD
Haloperidol—Body temperature increased—Levothyroxine—hypothyroidism	0.0021	0.00656	CcSEcCtD
Haloperidol—Body temperature increased—Dextrothyroxine—hypothyroidism	0.0021	0.00656	CcSEcCtD
Haloperidol—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00208	0.00828	CbGeAlD
Haloperidol—Convulsion—Liotrix—hypothyroidism	0.00208	0.00648	CcSEcCtD
Haloperidol—Hypertension—Liotrix—hypothyroidism	0.00207	0.00646	CcSEcCtD
Haloperidol—Anxiety—Liotrix—hypothyroidism	0.00203	0.00635	CcSEcCtD
Haloperidol—Confusional state—Liotrix—hypothyroidism	0.00197	0.00615	CcSEcCtD
Haloperidol—Anaphylactic shock—Liotrix—hypothyroidism	0.00196	0.0061	CcSEcCtD
Haloperidol—Oedema—Liotrix—hypothyroidism	0.00196	0.0061	CcSEcCtD
Haloperidol—H1F0—testis—hypothyroidism	0.00192	0.00764	CbGeAlD
Haloperidol—Tachycardia—Liotrix—hypothyroidism	0.00191	0.00596	CcSEcCtD
Haloperidol—Hyperhidrosis—Liotrix—hypothyroidism	0.00189	0.0059	CcSEcCtD
Haloperidol—Pruritus—Levothyroxine—hypothyroidism	0.00188	0.00587	CcSEcCtD
Haloperidol—Pruritus—Dextrothyroxine—hypothyroidism	0.00188	0.00587	CcSEcCtD
Haloperidol—SIGMAR1—pituitary gland—hypothyroidism	0.00188	0.00747	CbGeAlD
Haloperidol—Anorexia—Liotrix—hypothyroidism	0.00186	0.00582	CcSEcCtD
Haloperidol—Hypotension—Liotrix—hypothyroidism	0.00183	0.0057	CcSEcCtD
Haloperidol—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00182	0.00568	CcSEcCtD
Haloperidol—Diarrhoea—Levothyroxine—hypothyroidism	0.00182	0.00568	CcSEcCtD
Haloperidol—H1F0—liver—hypothyroidism	0.00181	0.00722	CbGeAlD
Haloperidol—KCNH2—heart—hypothyroidism	0.00179	0.00711	CbGeAlD
Haloperidol—H1F0—cerebellum—hypothyroidism	0.00177	0.00706	CbGeAlD
Haloperidol—Insomnia—Liotrix—hypothyroidism	0.00177	0.00552	CcSEcCtD
Haloperidol—Dyspnoea—Liotrix—hypothyroidism	0.00174	0.00544	CcSEcCtD
Haloperidol—Decreased appetite—Liotrix—hypothyroidism	0.0017	0.00531	CcSEcCtD
Haloperidol—Vomiting—Dextrothyroxine—hypothyroidism	0.00169	0.00528	CcSEcCtD
Haloperidol—Vomiting—Levothyroxine—hypothyroidism	0.00169	0.00528	CcSEcCtD
Haloperidol—KCNH2—cardiovascular system—hypothyroidism	0.00169	0.00671	CbGeAlD
Haloperidol—Rash—Dextrothyroxine—hypothyroidism	0.00168	0.00523	CcSEcCtD
Haloperidol—Rash—Levothyroxine—hypothyroidism	0.00168	0.00523	CcSEcCtD
Haloperidol—SIGMAR1—adrenal gland—hypothyroidism	0.00168	0.00667	CbGeAlD
Haloperidol—SIGMAR1—blood—hypothyroidism	0.00167	0.00667	CbGeAlD
Haloperidol—Dermatitis—Dextrothyroxine—hypothyroidism	0.00167	0.00523	CcSEcCtD
Haloperidol—Dermatitis—Levothyroxine—hypothyroidism	0.00167	0.00523	CcSEcCtD
Haloperidol—Constipation—Liotrix—hypothyroidism	0.00167	0.00522	CcSEcCtD
Haloperidol—HTR2B—adrenal gland—hypothyroidism	0.00167	0.00666	CbGeAlD
Haloperidol—HTR2B—blood—hypothyroidism	0.00167	0.00666	CbGeAlD
Haloperidol—Headache—Dextrothyroxine—hypothyroidism	0.00167	0.0052	CcSEcCtD
Haloperidol—Headache—Levothyroxine—hypothyroidism	0.00167	0.0052	CcSEcCtD
Haloperidol—SIGMAR1—thyroid gland—hypothyroidism	0.00162	0.00644	CbGeAlD
Haloperidol—HTR2B—thyroid gland—hypothyroidism	0.00161	0.00642	CbGeAlD
Haloperidol—Feeling abnormal—Liotrix—hypothyroidism	0.00161	0.00503	CcSEcCtD
Haloperidol—Nausea—Levothyroxine—hypothyroidism	0.00158	0.00493	CcSEcCtD
Haloperidol—Nausea—Dextrothyroxine—hypothyroidism	0.00158	0.00493	CcSEcCtD
Haloperidol—SIGMAR1—female gonad—hypothyroidism	0.00156	0.00622	CbGeAlD
Haloperidol—Urticaria—Liotrix—hypothyroidism	0.00155	0.00485	CcSEcCtD
Haloperidol—Body temperature increased—Liotrix—hypothyroidism	0.00155	0.00483	CcSEcCtD
Haloperidol—DRD2—pituitary gland—hypothyroidism	0.00151	0.00603	CbGeAlD
Haloperidol—CYP1A1—heart—hypothyroidism	0.00151	0.00601	CbGeAlD
Haloperidol—KCNH2—pituitary gland—hypothyroidism	0.00149	0.00594	CbGeAlD
Haloperidol—CYP2C9—heart—hypothyroidism	0.00145	0.00578	CbGeAlD
Haloperidol—Hypersensitivity—Liotrix—hypothyroidism	0.00144	0.0045	CcSEcCtD
Haloperidol—CYP2C19—blood—hypothyroidism	0.0014	0.00556	CbGeAlD
Haloperidol—SIGMAR1—testis—hypothyroidism	0.00139	0.00552	CbGeAlD
Haloperidol—Pruritus—Liotrix—hypothyroidism	0.00138	0.00432	CcSEcCtD
Haloperidol—CYP2C9—cardiovascular system—hypothyroidism	0.00137	0.00546	CbGeAlD
Haloperidol—Diarrhoea—Liotrix—hypothyroidism	0.00134	0.00418	CcSEcCtD
Haloperidol—KCNH2—adrenal gland—hypothyroidism	0.00133	0.00531	CbGeAlD
Haloperidol—KCNH2—blood—hypothyroidism	0.00133	0.00531	CbGeAlD
Haloperidol—SIGMAR1—liver—hypothyroidism	0.00131	0.00522	CbGeAlD
Haloperidol—Dizziness—Liotrix—hypothyroidism	0.00129	0.00404	CcSEcCtD
Haloperidol—SIGMAR1—cerebellum—hypothyroidism	0.00128	0.0051	CbGeAlD
Haloperidol—Vomiting—Liotrix—hypothyroidism	0.00124	0.00388	CcSEcCtD
Haloperidol—KCNH2—female gonad—hypothyroidism	0.00124	0.00495	CbGeAlD
Haloperidol—Rash—Liotrix—hypothyroidism	0.00123	0.00385	CcSEcCtD
Haloperidol—Dermatitis—Liotrix—hypothyroidism	0.00123	0.00384	CcSEcCtD
Haloperidol—Headache—Liotrix—hypothyroidism	0.00123	0.00382	CcSEcCtD
Haloperidol—HTR2A—heart—hypothyroidism	0.0012	0.00476	CbGeAlD
Haloperidol—Nausea—Liotrix—hypothyroidism	0.00116	0.00363	CcSEcCtD
Haloperidol—CYP1A2—blood—hypothyroidism	0.00114	0.00455	CbGeAlD
Haloperidol—HTR2A—cardiovascular system—hypothyroidism	0.00113	0.00449	CbGeAlD
Haloperidol—CYP1A1—blood—hypothyroidism	0.00113	0.00448	CbGeAlD
Haloperidol—DRD2—testis—hypothyroidism	0.00112	0.00446	CbGeAlD
Haloperidol—KCNH2—testis—hypothyroidism	0.0011	0.00439	CbGeAlD
Haloperidol—CYP1A2—thyroid gland—hypothyroidism	0.0011	0.00439	CbGeAlD
Haloperidol—CYP3A5—blood—hypothyroidism	0.0011	0.00438	CbGeAlD
Haloperidol—CYP2C19—liver—hypothyroidism	0.00109	0.00435	CbGeAlD
Haloperidol—CYP1A1—thyroid gland—hypothyroidism	0.00109	0.00433	CbGeAlD
Haloperidol—CYP2C9—blood—hypothyroidism	0.00108	0.00431	CbGeAlD
Haloperidol—HRH1—adrenal gland—hypothyroidism	0.00107	0.00426	CbGeAlD
Haloperidol—CYP1A1—female gonad—hypothyroidism	0.00105	0.00418	CbGeAlD
Haloperidol—DRD2—cerebellum—hypothyroidism	0.00103	0.00412	CbGeAlD
Haloperidol—CYP3A5—female gonad—hypothyroidism	0.00103	0.00409	CbGeAlD
Haloperidol—HTR2A—gonad—hypothyroidism	0.00102	0.00408	CbGeAlD
Haloperidol—KCNH2—cerebellum—hypothyroidism	0.00102	0.00406	CbGeAlD
Haloperidol—HTR2A—pituitary gland—hypothyroidism	0.000999	0.00398	CbGeAlD
Haloperidol—HRH1—female gonad—hypothyroidism	0.000996	0.00397	CbGeAlD
Haloperidol—HTR2A—adrenal gland—hypothyroidism	0.000893	0.00355	CbGeAlD
Haloperidol—CYP1A2—liver—hypothyroidism	0.000893	0.00355	CbGeAlD
Haloperidol—HTR2A—blood—hypothyroidism	0.000892	0.00355	CbGeAlD
Haloperidol—HRH1—testis—hypothyroidism	0.000884	0.00352	CbGeAlD
Haloperidol—CYP1A1—liver—hypothyroidism	0.00088	0.00351	CbGeAlD
Haloperidol—CYP3A5—liver—hypothyroidism	0.000861	0.00343	CbGeAlD
Haloperidol—CYP2C9—liver—hypothyroidism	0.000847	0.00337	CbGeAlD
Haloperidol—CYP3A4—blood—hypothyroidism	0.000826	0.00329	CbGeAlD
Haloperidol—CYP2D6—blood—hypothyroidism	0.000813	0.00324	CbGeAlD
Haloperidol—ABCB1—adrenal cortex—hypothyroidism	0.00081	0.00323	CbGeAlD
Haloperidol—ABCB1—heart—hypothyroidism	0.000784	0.00312	CbGeAlD
Haloperidol—CYP2D6—female gonad—hypothyroidism	0.000758	0.00302	CbGeAlD
Haloperidol—ABCB1—cardiovascular system—hypothyroidism	0.000739	0.00294	CbGeAlD
Haloperidol—HTR2A—testis—hypothyroidism	0.000738	0.00294	CbGeAlD
Haloperidol—HTR2A—liver—hypothyroidism	0.000698	0.00278	CbGeAlD
Haloperidol—HTR2A—cerebellum—hypothyroidism	0.000682	0.00271	CbGeAlD
Haloperidol—CYP2D6—testis—hypothyroidism	0.000672	0.00268	CbGeAlD
Haloperidol—ABCB1—gonad—hypothyroidism	0.000671	0.00267	CbGeAlD
Haloperidol—ABCB1—pituitary gland—hypothyroidism	0.000655	0.00261	CbGeAlD
Haloperidol—CYP3A4—liver—hypothyroidism	0.000646	0.00257	CbGeAlD
Haloperidol—CYP2D6—liver—hypothyroidism	0.000636	0.00253	CbGeAlD
Haloperidol—CYP2D6—cerebellum—hypothyroidism	0.000621	0.00247	CbGeAlD
Haloperidol—ABCB1—adrenal gland—hypothyroidism	0.000585	0.00233	CbGeAlD
Haloperidol—ABCB1—blood—hypothyroidism	0.000585	0.00233	CbGeAlD
Haloperidol—ABCB1—thyroid gland—hypothyroidism	0.000564	0.00225	CbGeAlD
Haloperidol—ABCB1—female gonad—hypothyroidism	0.000545	0.00217	CbGeAlD
Haloperidol—ABCB1—testis—hypothyroidism	0.000484	0.00193	CbGeAlD
Haloperidol—ABCB1—liver—hypothyroidism	0.000457	0.00182	CbGeAlD
Haloperidol—ABCB1—cerebellum—hypothyroidism	0.000447	0.00178	CbGeAlD
Haloperidol—CYP1A1—Metabolism—TPO—hypothyroidism	9.78e-05	0.000896	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—IYD—hypothyroidism	9.77e-05	0.000895	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CLTC—hypothyroidism	9.68e-05	0.000887	CbGpPWpGaD
Haloperidol—HTR1D—GPCR ligand binding—POMC—hypothyroidism	9.64e-05	0.000883	CbGpPWpGaD
Haloperidol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.61e-05	0.00088	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—AVP—hypothyroidism	9.5e-05	0.00087	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CLTC—hypothyroidism	9.48e-05	0.000868	CbGpPWpGaD
Haloperidol—HTR1B—GPCR ligand binding—POMC—hypothyroidism	9.44e-05	0.000864	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—AVP—hypothyroidism	9.35e-05	0.000856	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CLTC—hypothyroidism	9.33e-05	0.000854	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—AVP—hypothyroidism	9.33e-05	0.000854	CbGpPWpGaD
Haloperidol—DRD4—GPCR ligand binding—POMC—hypothyroidism	9.29e-05	0.00085	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—TRH—hypothyroidism	9.28e-05	0.00085	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—IYD—hypothyroidism	9.21e-05	0.000843	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—TRH—hypothyroidism	9.13e-05	0.000836	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—IYD—hypothyroidism	9.13e-05	0.000836	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—TRH—hypothyroidism	9.11e-05	0.000834	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	9.11e-05	0.000834	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	9.11e-05	0.000834	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.06e-05	0.00083	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	8.96e-05	0.000821	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	8.96e-05	0.000821	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	8.94e-05	0.000819	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	8.94e-05	0.000819	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CLTC—hypothyroidism	8.91e-05	0.000816	CbGpPWpGaD
Haloperidol—HTR2B—GPCR ligand binding—POMC—hypothyroidism	8.87e-05	0.000812	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ATP5O—hypothyroidism	8.51e-05	0.00078	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—VAV3—hypothyroidism	8.51e-05	0.000779	CbGpPWpGaD
Haloperidol—CYP2C19—Biological oxidations—POMC—hypothyroidism	8.49e-05	0.000777	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CLTC—hypothyroidism	8.4e-05	0.000769	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TRH—hypothyroidism	8.37e-05	0.000766	CbGpPWpGaD
Haloperidol—DRD1—GPCR ligand binding—POMC—hypothyroidism	8.36e-05	0.000766	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—VAV3—hypothyroidism	8.33e-05	0.000763	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ATP5O—hypothyroidism	8.31e-05	0.000761	CbGpPWpGaD
Haloperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.29e-05	0.000759	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CLTC—hypothyroidism	8.29e-05	0.000759	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—TSHB—hypothyroidism	8.27e-05	0.000757	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—TSHR—hypothyroidism	8.27e-05	0.000757	CbGpPWpGaD
Haloperidol—DRD3—GPCR ligand binding—POMC—hypothyroidism	8.25e-05	0.000755	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—VAV3—hypothyroidism	8.2e-05	0.000751	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—AVP—hypothyroidism	8.2e-05	0.00075	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TRH—hypothyroidism	8.2e-05	0.00075	CbGpPWpGaD
Haloperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.16e-05	0.000747	CbGpPWpGaD
Haloperidol—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.14e-05	0.000745	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	8.14e-05	0.000745	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	8.14e-05	0.000745	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—TSHB—hypothyroidism	8.12e-05	0.000744	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—TSHR—hypothyroidism	8.12e-05	0.000744	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TRH—hypothyroidism	8.06e-05	0.000738	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—AVP—hypothyroidism	8.03e-05	0.000735	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—TPO—hypothyroidism	8e-05	0.000733	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—AVP—hypothyroidism	7.9e-05	0.000723	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—TSHB—hypothyroidism	7.88e-05	0.000722	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ATP5O—hypothyroidism	7.83e-05	0.000717	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	7.82e-05	0.000716	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TPO—hypothyroidism	7.81e-05	0.000715	CbGpPWpGaD
Haloperidol—CYP2D6—Biological oxidations—POMC—hypothyroidism	7.81e-05	0.000715	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—IYD—hypothyroidism	7.8e-05	0.000714	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ATP5O—hypothyroidism	7.76e-05	0.000711	CbGpPWpGaD
Haloperidol—CYP2C9—Biological oxidations—POMC—hypothyroidism	7.74e-05	0.000709	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—VAV3—hypothyroidism	7.73e-05	0.000707	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TRH—hypothyroidism	7.7e-05	0.000705	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—VAV3—hypothyroidism	7.56e-05	0.000693	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	7.54e-05	0.00069	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TSHB—hypothyroidism	7.46e-05	0.000683	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TSHR—hypothyroidism	7.46e-05	0.000683	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—VAV3—hypothyroidism	7.44e-05	0.000682	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—AVP—hypothyroidism	7.44e-05	0.000682	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.42e-05	0.000679	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—VAV3—hypothyroidism	7.38e-05	0.000676	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TPO—hypothyroidism	7.36e-05	0.000674	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	7.33e-05	0.000671	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TSHR—hypothyroidism	7.3e-05	0.000669	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TSHB—hypothyroidism	7.3e-05	0.000669	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TPO—hypothyroidism	7.3e-05	0.000668	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—AVP—hypothyroidism	7.29e-05	0.000667	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—VAV3—hypothyroidism	7.28e-05	0.000667	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TRH—hypothyroidism	7.26e-05	0.000665	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TSHB—hypothyroidism	7.19e-05	0.000658	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TSHR—hypothyroidism	7.19e-05	0.000658	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—AVP—hypothyroidism	7.17e-05	0.000657	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TRH—hypothyroidism	7.16e-05	0.000656	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—AVP—hypothyroidism	7.11e-05	0.000651	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	7.11e-05	0.000651	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PIK3C2A—hypothyroidism	7.03e-05	0.000643	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AVP—hypothyroidism	7.01e-05	0.000642	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.93e-05	0.000635	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TSHB—hypothyroidism	6.86e-05	0.000628	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TSHR—hypothyroidism	6.86e-05	0.000628	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AVP—hypothyroidism	6.85e-05	0.000627	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.76e-05	0.000619	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—VAV3—hypothyroidism	6.7e-05	0.000614	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	6.65e-05	0.000609	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ATP5O—hypothyroidism	6.63e-05	0.000607	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—TSHB—hypothyroidism	6.63e-05	0.000607	CbGpPWpGaD
Haloperidol—CYP1A2—Biological oxidations—POMC—hypothyroidism	6.61e-05	0.000605	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—VAV3—hypothyroidism	6.61e-05	0.000605	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	6.51e-05	0.000596	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TSHR—hypothyroidism	6.47e-05	0.000593	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TSHB—hypothyroidism	6.47e-05	0.000593	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AVP—hypothyroidism	6.46e-05	0.000591	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SH2B3—hypothyroidism	6.41e-05	0.000587	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TSHB—hypothyroidism	6.38e-05	0.000585	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TSHR—hypothyroidism	6.38e-05	0.000585	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AVP—hypothyroidism	6.37e-05	0.000583	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CLTC—hypothyroidism	6.34e-05	0.000581	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—POMC—hypothyroidism	6.31e-05	0.000578	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CLTC—hypothyroidism	6.24e-05	0.000571	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TPO—hypothyroidism	6.24e-05	0.000571	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CLTC—hypothyroidism	6.23e-05	0.00057	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—POMC—hypothyroidism	6.21e-05	0.000569	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—POMC—hypothyroidism	6.2e-05	0.000567	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	6.12e-05	0.00056	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—IYD—hypothyroidism	6.02e-05	0.000551	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	5.91e-05	0.000541	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—SLC5A5—hypothyroidism	5.9e-05	0.00054	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.78e-05	0.000529	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.78e-05	0.000529	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SH2B3—hypothyroidism	5.77e-05	0.000528	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SH2B3—hypothyroidism	5.69e-05	0.000521	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	5.57e-05	0.00051	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	5.48e-05	0.000502	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TRH—hypothyroidism	5.48e-05	0.000502	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	5.47e-05	0.000501	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	5.45e-05	0.000499	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TRH—hypothyroidism	5.39e-05	0.000494	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TRH—hypothyroidism	5.38e-05	0.000493	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AVP—hypothyroidism	5.37e-05	0.000491	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	5.33e-05	0.000488	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	5.28e-05	0.000484	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AVP—hypothyroidism	5.27e-05	0.000483	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—POMC—hypothyroidism	5.25e-05	0.000481	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.12e-05	0.000469	CbGpPWpGaD
Haloperidol—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.1e-05	0.000467	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—VAV3—hypothyroidism	5.06e-05	0.000463	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	5.01e-05	0.000459	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	4.98e-05	0.000456	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—VAV3—hypothyroidism	4.97e-05	0.000455	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—SLC5A5—hypothyroidism	4.96e-05	0.000455	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—POMC—hypothyroidism	4.95e-05	0.000453	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PRL—hypothyroidism	4.93e-05	0.000452	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TSHR—hypothyroidism	4.89e-05	0.000447	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TSHB—hypothyroidism	4.89e-05	0.000447	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AVP—hypothyroidism	4.87e-05	0.000446	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—POMC—hypothyroidism	4.84e-05	0.000443	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PRL—hypothyroidism	4.83e-05	0.000442	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TPO—hypothyroidism	4.81e-05	0.000441	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TSHR—hypothyroidism	4.81e-05	0.00044	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TSHB—hypothyroidism	4.81e-05	0.00044	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TSHB—hypothyroidism	4.8e-05	0.000439	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TSHR—hypothyroidism	4.8e-05	0.000439	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AVP—hypothyroidism	4.8e-05	0.000439	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—TSHB—hypothyroidism	4.79e-05	0.000439	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AVP—hypothyroidism	4.79e-05	0.000438	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—POMC—hypothyroidism	4.77e-05	0.000436	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PRL—hypothyroidism	4.75e-05	0.000435	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—POMC—hypothyroidism	4.72e-05	0.000433	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—POMC—hypothyroidism	4.66e-05	0.000427	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VAV3—hypothyroidism	4.56e-05	0.000418	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.55e-05	0.000417	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—POMC—hypothyroidism	4.55e-05	0.000417	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PRL—hypothyroidism	4.54e-05	0.000415	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—TSHB—hypothyroidism	4.53e-05	0.000415	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VAV3—hypothyroidism	4.47e-05	0.000409	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VAV3—hypothyroidism	4.4e-05	0.000403	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AVP—hypothyroidism	4.4e-05	0.000403	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SH2B3—hypothyroidism	4.35e-05	0.000399	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AVP—hypothyroidism	4.31e-05	0.000394	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—POMC—hypothyroidism	4.29e-05	0.000393	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	4.28e-05	0.000392	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PRL—hypothyroidism	4.28e-05	0.000392	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SH2B3—hypothyroidism	4.28e-05	0.000391	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	4.27e-05	0.000391	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AVP—hypothyroidism	4.24e-05	0.000388	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—POMC—hypothyroidism	4.23e-05	0.000388	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PRL—hypothyroidism	4.22e-05	0.000387	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VAV3—hypothyroidism	4.2e-05	0.000384	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AVP—hypothyroidism	4.04e-05	0.00037	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	4.04e-05	0.00037	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.98e-05	0.000365	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VAV3—hypothyroidism	3.96e-05	0.000362	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VAV3—hypothyroidism	3.91e-05	0.000358	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AVP—hypothyroidism	3.81e-05	0.000349	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AVP—hypothyroidism	3.76e-05	0.000345	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—TSHB—hypothyroidism	3.71e-05	0.000339	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TSHB—hypothyroidism	3.62e-05	0.000331	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—SLC5A5—hypothyroidism	3.59e-05	0.000329	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—POMC—hypothyroidism	3.57e-05	0.000327	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	3.51e-05	0.000321	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—POMC—hypothyroidism	3.5e-05	0.000321	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TSHB—hypothyroidism	3.41e-05	0.000312	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—SLC5A5—hypothyroidism	3.39e-05	0.00031	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TSHB—hypothyroidism	3.38e-05	0.000309	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	3.3e-05	0.000302	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.26e-05	0.000298	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—POMC—hypothyroidism	3.24e-05	0.000297	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PRL—hypothyroidism	3.23e-05	0.000296	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.22e-05	0.000295	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—POMC—hypothyroidism	3.19e-05	0.000292	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—POMC—hypothyroidism	3.18e-05	0.000291	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PRL—hypothyroidism	3.18e-05	0.000291	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PRL—hypothyroidism	3.17e-05	0.00029	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—POMC—hypothyroidism	3.09e-05	0.000283	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	3.04e-05	0.000278	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	3.01e-05	0.000276	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VAV3—hypothyroidism	2.99e-05	0.000274	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.97e-05	0.000272	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VAV3—hypothyroidism	2.94e-05	0.000269	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VAV3—hypothyroidism	2.93e-05	0.000269	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—POMC—hypothyroidism	2.92e-05	0.000268	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TSHB—hypothyroidism	2.89e-05	0.000264	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AVP—hypothyroidism	2.88e-05	0.000264	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—POMC—hypothyroidism	2.86e-05	0.000262	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AVP—hypothyroidism	2.83e-05	0.000259	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AVP—hypothyroidism	2.83e-05	0.000259	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—POMC—hypothyroidism	2.82e-05	0.000258	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IGF1—hypothyroidism	2.81e-05	0.000257	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.77e-05	0.000254	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IGF1—hypothyroidism	2.75e-05	0.000252	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IGF1—hypothyroidism	2.71e-05	0.000248	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.71e-05	0.000248	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—POMC—hypothyroidism	2.69e-05	0.000246	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—POMC—hypothyroidism	2.6e-05	0.000238	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IGF1—hypothyroidism	2.59e-05	0.000237	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.57e-05	0.000236	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—SLC5A5—hypothyroidism	2.55e-05	0.000234	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.54e-05	0.000233	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—POMC—hypothyroidism	2.53e-05	0.000232	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—SLC5A5—hypothyroidism	2.53e-05	0.000232	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—POMC—hypothyroidism	2.5e-05	0.000229	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IGF1—hypothyroidism	2.44e-05	0.000223	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IGF1—hypothyroidism	2.41e-05	0.00022	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TSHB—hypothyroidism	2.23e-05	0.000204	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.16e-05	0.000198	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.99e-05	0.000182	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—POMC—hypothyroidism	1.91e-05	0.000175	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—POMC—hypothyroidism	1.88e-05	0.000172	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—POMC—hypothyroidism	1.88e-05	0.000172	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—POMC—hypothyroidism	1.88e-05	0.000172	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IGF1—hypothyroidism	1.84e-05	0.000169	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IGF1—hypothyroidism	1.81e-05	0.000166	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IGF1—hypothyroidism	1.81e-05	0.000165	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—POMC—hypothyroidism	1.77e-05	0.000162	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.67e-05	0.000153	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—POMC—hypothyroidism	1.45e-05	0.000133	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—POMC—hypothyroidism	1.42e-05	0.00013	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—POMC—hypothyroidism	1.33e-05	0.000122	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—POMC—hypothyroidism	1.32e-05	0.000121	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—POMC—hypothyroidism	1.13e-05	0.000104	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—POMC—hypothyroidism	8.73e-06	7.99e-05	CbGpPWpGaD
